Found: 48
Select item for more details and to access through your institution.
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1714, doi. 10.1111/dom.15479
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1473, doi. 10.1111/dom.14993
- By:
- Publication type:
- Article
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2379, doi. 10.1111/dom.13377
- By:
- Publication type:
- Article
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1732, doi. 10.1111/dom.13292
- By:
- Publication type:
- Article
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 78, doi. 10.1111/dom.12786
- By:
- Publication type:
- Article
Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01603-8
- By:
- Publication type:
- Article
Roles for SGLT2 Inhibitors in Cardiorenal Disease.
- Published in:
- CardioRenal Medicine, 2022, v. 12, n. 3, p. 81, doi. 10.1159/000524906
- By:
- Publication type:
- Article
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE).
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 4, p. 894, doi. 10.1093/ndt/gfac198
- By:
- Publication type:
- Article
Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors
- Published in:
- Clinical Cardiology, 2022, v. 45, n. 7, p. 794, doi. 10.1002/clc.23844
- By:
- Publication type:
- Article
The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 9, p. 1259, doi. 10.1002/clc.23054
- By:
- Publication type:
- Article
Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 1, p. 38, doi. 10.1002/clc.22603
- By:
- Publication type:
- Article
Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2026, doi. 10.1002/ejhf.1958
- By:
- Publication type:
- Article
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lower Levels of Circulating Progenitor Cells Are Associated With Low Physical Function and Performance in Elderly Men With Impaired Glucose Tolerance: A Pilot Substudy From the VA Enhanced Fitness Trial.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2013, v. 68, n. 12, p. 1559, doi. 10.1093/gerona/glt067
- By:
- Publication type:
- Article
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 11, p. 1390, doi. 10.1002/ejhf.933
- By:
- Publication type:
- Article
Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.
- Published in:
- American Journal of Hypertension, 2015, v. 28, n. 8, p. 995, doi. 10.1093/ajh/hpu292
- By:
- Publication type:
- Article
Clinical utility of fixed combinations of sitagliptin-metformin in treatment of type 2 diabetes.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2010, v. 3, p. 363, doi. 10.2147/DMSOTT.S10195
- By:
- Publication type:
- Article
"The price is right" for diabetes management of older adults – Evidence for the closest glycemic target without going over.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 12, p. 3680, doi. 10.1111/jgs.18658
- By:
- Publication type:
- Article
Enhanced Fitness: A Randomized Controlled Trial of the Effects of Home-Based Physical Activity Counseling on Glycemic Control in Older Adults with Prediabetes Mellitus.
- Published in:
- Journal of the American Geriatrics Society, 2012, v. 60, n. 9, p. 1655, doi. 10.1111/j.1532-5415.2012.04119.x
- By:
- Publication type:
- Article
Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes.
- Published in:
- Clinical Medicine: Therapeutics, 2009, n. 1, p. 1103, doi. 10.4137/CMT.S2109
- By:
- Publication type:
- Article
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 15, p. 1261, doi. 10.1001/jama.2023.2854
- By:
- Publication type:
- Article
Update in Endocrinology: Evidence Published in 2014.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Are sulfonylureas passé?
- Published in:
- 2006
- By:
- Publication type:
- journal article
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
- Published in:
- Clinical Kidney Journal, 2020, v. 13, n. 4, p. 722, doi. 10.1093/ckj/sfz009
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy.
- Published in:
- Drug, Healthcare & Patient Safety, 2010, v. 2, p. 7
- By:
- Publication type:
- Article
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2148030, doi. 10.1001/jamanetworkopen.2021.48030
- By:
- Publication type:
- Article
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 7, p. e2117963, doi. 10.1001/jamanetworkopen.2021.17963
- By:
- Publication type:
- Article
Progression of glucose‐lowering diabetes therapy in TECOS.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/edm2.53
- By:
- Publication type:
- Article
Validation of the WATCH-DM and TRS-HF<sub>DM</sub> Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors.
- Published in:
- Journal of Managed Care Medicine, 2021, v. 24, n. 2, p. 67
- By:
- Publication type:
- Article
Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0156068
- By:
- Publication type:
- Article
The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice.
- Published in:
- Diabetes Care, 2024, v. 47, n. 8, p. 1299, doi. 10.2337/dci24-0001
- By:
- Publication type:
- Article
Reflecting on a Year at the Helm of Diabetes Care.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
"The Times They Are A-Changin'" at Diabetes Care.
- Published in:
- Diabetes Care, 2023, v. 46, n. 1, p. 3, doi. 10.2337/dci22-0045
- By:
- Publication type:
- Article
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163.
- Published in:
- 2019
- By:
- Publication type:
- letter
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Editors' Expert Forum.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pancreatic Safety of Sitagliptin in the TECOS Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial.
- Published in:
- Diabetes Care, 2012, v. 35, n. 7, p. 1525, doi. 10.2337/dc11-2184
- By:
- Publication type:
- Article